WOODCAST Hand Resting Splint - Study of User Experience
User Experience From WOODCAST 2mm Hand Resting Splint
1 other identifier
observational
18
1 country
1
Brief Summary
The aim of the study is to collect comments form users of new type of hand resting splint.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Apr 2013
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2013
CompletedFirst Submitted
Initial submission to the registry
May 31, 2013
CompletedFirst Posted
Study publicly available on registry
June 5, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2016
CompletedJune 14, 2017
June 1, 2017
3.4 years
May 31, 2013
June 13, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
User satisfaction
After using hand resting splint for two weeks, patient will fill a questionaire. In the questionaire patient is asked to assess the used splint (e.g. functional performance, visual appearance), by giving points (from 1 to 10 points). Patient will use two splints from different materials during the treatment (both of the splint will be assessed by the patient).
2-4 weeks
Study Arms (1)
hand resting splint
Patients with hand resting splint treatment
Eligibility Criteria
Patients whos treatment involves a hand resting splint. Finnish language skills (written and spoken).
You may qualify if:
- patient treatment involves hand resting splint; age of patient 18 - 90 years; skills with language Finnish language (written and spoken)
You may not qualify if:
- decreased co-operation of the patient; patient with multiple illnesses; malignancy; an illness affecting the general health.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Onbone Oylead
Study Sites (1)
Kuntoutus Orton Oy
Helsinki, 00280, Finland
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Nina Lindfors, PhD, MD
Helsinki University Central Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 31, 2013
First Posted
June 5, 2013
Study Start
April 1, 2013
Primary Completion
September 1, 2016
Study Completion
September 1, 2016
Last Updated
June 14, 2017
Record last verified: 2017-06
Data Sharing
- IPD Sharing
- Will not share